Biontech SE

Common Name
Biontech
Country
Germany
Sector
Healthcare
Industry
Biotechnology
Employees
6,772
Ticker
BNTX
Exchange
NASDAQ/NGS
Description
BioNTech SE is a biotechnology company, represented in the financial market through American Depositary Receipts (ADRs). This setup allows American investors to own shares in BioNTech, a German-based ...

Biontech's GHG Emissions Data Preview

In 2024, Biontech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

However, Biontech has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Biontech’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Biontech’s data sources below and access millions more through our Disclosure Search.

a. Biontech's Sustainability Report 2024
a. Biontech's Sustainability Report 2024
b. Biontech's Sustainability Report 2022
b. Biontech's Sustainability Report 2022
c. Biontech's Sustainability Report 2023
c. Biontech's Sustainability Report 2023

Insights into Biontech's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Biontech amounted to 18,610 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Biontech increased by 297.56%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Biontech's Scope 1 Emissions Over Time

20192020202120222023202406501.3 k1.95 k2.6 ktCO2e+16%+26%-2%+55%+79%
  • Total Scope 1
  • Year-over-Year Change

What are Biontech's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Biontech were 2,405 metric tons of CO₂ equivalent (tCO₂e). a

Has Biontech reduced its Scope 1 emissions over time?

Since 2019, Biontech's Scope 1 emissions have increased by 296.21%, reflecting a rising long-term trend in Scope 1 emissions over time. a c

Compared to the previous year (2023), Biontech's Scope 1 emissions increased by 79.21%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are Biontech's Scope 2 emissions?

In 2024, Biontech reported Scope 2 greenhouse gas (GHG) emissions of 4,044 tCO₂e using the market-based method and 16,205 tCO₂e using the location-based method. a

What methodology does Biontech use for Scope 2 reporting?

In 2024, Biontech reported its Scope 2 emissions using the market-based method and using the location-based method. a

Biontech's Scope 2 Emissions Over Time

20192020202120222023202404.5 k9 k13.5 k18 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Biontech's Value Chain Emissions

In 2024, Biontech reported 886,448 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2024 disclosure of Biontech includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a

Biontech's Scope 3 Emissions Over Time

2019202020212022202320240400 k800 k1.2 M1.6 MtCO2e-34%+88979%-23%-53%+67%
  • Total Scope 3
  • Year-over-Year Change

What are Biontech's Scope 3 emissions?

In 2024, Biontech reported total Scope 3 emissions of 886,448 metric tons of CO₂ equivalent (tCO₂e). a

Has Biontech reduced its Scope 3 emissions over time?

Since 2019, Biontech's Scope 3 emissions have increased by 36,155.54%, reflecting a rising long-term trend in Scope 3 emissions over time. a c

Compared to the previous year (2023), Biontech's Scope 3 emissions increased by 67.41%, suggesting that the company faced challenges in reducing emissions across its value chain. a

Insights into Biontech’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Biontech reported Scope 1 greenhouse gas (GHG) emissions of 2,405 tCO₂e and total revenues of USD 3,341 millions. This translates into an emissions intensity of 0.72 tCO₂e per millions USD. a

Biontech's Scope 1 Emissions Intensity Compared to Peers

101001,00010,000100,000Scope 1 Emissions (tCO2e)0.251002,000100,000Revenues (Millions of USD)CGenmabYear: 2024Scope 1: 534 tCO2eRevenue: $M 3,003Scope 1 Intensity: 0.18 tCO2e/$MIncyteYear: 2024Scope 1: 9,576 tCO2eRevenue: $M 4,241Scope 1 Intensity: 2.26 tCO2e/$MBio-TechneYear: 2023Scope 1: 3,001 tCO2eRevenue: $M 1,137Scope 1 Intensity: 2.64 tCO2e/$MSino BiopharmaceuticalYear: 2024Scope 1: 18,239 tCO2eRevenue: $M 4,308Scope 1 Intensity: 4.23 tCO2e/$MInnovent BiologicsYear: 2023Scope 1: 65 tCO2eRevenue: $M 953Scope 1 Intensity: 0.07 tCO2e/$MAkesoYear: 2024Scope 1: 6,408 tCO2eRevenue: $M 318Scope 1 Intensity: 20.17 tCO2e/$MHalozyme TherapeuticsYear: 2024Scope 1: 1,348 tCO2eRevenue: $M 1,015Scope 1 Intensity: 1.33 tCO2e/$MCCConcord BiotechYear: 2025Scope 1: 13 tCO2eRevenue: $M 138Scope 1 Intensity: 0.09 tCO2e/$MModernaYear: 2023Scope 1: 11,240 tCO2eRevenue: $M 6,754Scope 1 Intensity: 1.66 tCO2e/$MOBI PharmaYear: 2022Scope 1: 25 tCO2eRevenue: $M 0Scope 1 Intensity: 165.23 tCO2e/$MSarepta TherapeuticsYear: 2023Scope 1: 3,428 tCO2eRevenue: $M 1,243Scope 1 Intensity: 2.76 tCO2e/$MZai LabYear: 2023Scope 1: 15 tCO2eRevenue: $M 267Scope 1 Intensity: 0.06 tCO2e/$MOxford Nanopore TechnologiesYear: 2024Scope 1: 313 tCO2eRevenue: $M 230Scope 1 Intensity: 1.36 tCO2e/$MBiotestYear: 2020Scope 1: 18,574 tCO2eRevenue: $M 384Scope 1 Intensity: 48.41 tCO2e/$MKintor PharmaceuticalYear: 2021Scope 1: 29 tCO2eRevenue: $M 5Scope 1 Intensity: 5.35 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$MBeOne MedicinesYear: 2024Scope 1: 3,547 tCO2eRevenue: $M 27,369Scope 1 Intensity: 0.13 tCO2e/$MValnevaYear: 2024Scope 1: 1,277 tCO2eRevenue: $M 176Scope 1 Intensity: 7.24 tCO2e/$MWuXi Biologics (Cayman)Year: 2023Scope 1: 32,687 tCO2eRevenue: $M 2,603Scope 1 Intensity: 12.56 tCO2e/$MAlphamab OncologyYear: 2023Scope 1: 3,970 tCO2eRevenue: $M 34Scope 1 Intensity: 117.90 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MGenor Biopharma HoldingsYear: 2022Scope 1: 18 tCO2eRevenue: $M 3Scope 1 Intensity: 7.17 tCO2e/$MIonis PharmaceuticalsYear: 2024Scope 1: 2,616 tCO2eRevenue: $M 705Scope 1 Intensity: 3.71 tCO2e/$MZealand PharmaYear: 2024Scope 1: 145 tCO2eRevenue: $M 9Scope 1 Intensity: 16.60 tCO2e/$MBiontechYear: 2024Scope 1: 2,405 tCO2eRevenue: $M 3,341Scope 1 Intensity: 0.72 tCO2e/$M

How does Biontech's GHG emissions intensity compare to its peers?

In 2024, Biontech reported a Scope 1 emissions intensity of 0.72 tCO₂e per millions USD. Compared to the peer group median of 3.97 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Biontech rank on GHG emissions intensity within its industry?

In 2024, Biontech ranked 6 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Biontech is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Insights into Biontech's Total Carbon Footprint

In 2024, Biontech reported a total carbon footprint of 905,058 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 69.43% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a

The largest contributor to Biontech's total carbon footprint was Scope 3 emissions, accounting for 97.94% of the company's total carbon footprint, followed by Scope 2 emissions at 1.79%. a

Want Full Access to Biontech's GHG Emissions Dataset?
Sign Up